肺癌侵犯上腔静脉的外科治疗。一篇简短的最新评论。

IF 0.6 Q4 SURGERY
Eleftherios Nikolaidis, Nikolaos Bolanos, Dimitrios Anagnostopoulos, Vasileios Leivaditis, Konstantinos Grapatsas, Efstratios Koletsis, Athanasios Papatriantafyllou, Ioannis Panagiotopoulos, Francesk Mulita, Nikolaos Baltayiannis, Manfred Dahm, Antonios Chatzimichalis
{"title":"肺癌侵犯上腔静脉的外科治疗。一篇简短的最新评论。","authors":"Eleftherios Nikolaidis,&nbsp;Nikolaos Bolanos,&nbsp;Dimitrios Anagnostopoulos,&nbsp;Vasileios Leivaditis,&nbsp;Konstantinos Grapatsas,&nbsp;Efstratios Koletsis,&nbsp;Athanasios Papatriantafyllou,&nbsp;Ioannis Panagiotopoulos,&nbsp;Francesk Mulita,&nbsp;Nikolaos Baltayiannis,&nbsp;Manfred Dahm,&nbsp;Antonios Chatzimichalis","doi":"10.5114/kitp.2023.129546","DOIUrl":null,"url":null,"abstract":"<p><p>Lung cancer is one of the leading causes of cancer-related deaths worldwide. Superior vena cava syndrome (SVCS) is a rare but potentially life-threatening complication of lung cancer, occurring in approximately 5-10% of cases. There are difficulties in the process of surgical treatment of SVC infiltrated by lung tumors but the contribution of technological evolution and innovation is promising. At the same time, the amelioration of survival rates of patients subjected to surgical treatment is equally promising. The reported outcomes of surgical treatment for SVC invasion due to lung tumors vary depending on the extent of the tumor and the patient's overall health status. However, studies clearly suggest that surgical treatment can improve survival and quality of life in selected patients. The literature review showed that the surgical approach to lung cancer invading the SVC constitutes the most indispensable treatment which helps to achieve the long-term survival of patients.</p>","PeriodicalId":49945,"journal":{"name":"Kardiochirurgia I Torakochirurgia Polska","volume":null,"pages":null},"PeriodicalIF":0.6000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/99/46/KITP-20-51119.PMC10410641.pdf","citationCount":"0","resultStr":"{\"title\":\"Lung cancer invading the superior vena cava - surgical treatment. A short and up-to-date review.\",\"authors\":\"Eleftherios Nikolaidis,&nbsp;Nikolaos Bolanos,&nbsp;Dimitrios Anagnostopoulos,&nbsp;Vasileios Leivaditis,&nbsp;Konstantinos Grapatsas,&nbsp;Efstratios Koletsis,&nbsp;Athanasios Papatriantafyllou,&nbsp;Ioannis Panagiotopoulos,&nbsp;Francesk Mulita,&nbsp;Nikolaos Baltayiannis,&nbsp;Manfred Dahm,&nbsp;Antonios Chatzimichalis\",\"doi\":\"10.5114/kitp.2023.129546\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Lung cancer is one of the leading causes of cancer-related deaths worldwide. Superior vena cava syndrome (SVCS) is a rare but potentially life-threatening complication of lung cancer, occurring in approximately 5-10% of cases. There are difficulties in the process of surgical treatment of SVC infiltrated by lung tumors but the contribution of technological evolution and innovation is promising. At the same time, the amelioration of survival rates of patients subjected to surgical treatment is equally promising. The reported outcomes of surgical treatment for SVC invasion due to lung tumors vary depending on the extent of the tumor and the patient's overall health status. However, studies clearly suggest that surgical treatment can improve survival and quality of life in selected patients. The literature review showed that the surgical approach to lung cancer invading the SVC constitutes the most indispensable treatment which helps to achieve the long-term survival of patients.</p>\",\"PeriodicalId\":49945,\"journal\":{\"name\":\"Kardiochirurgia I Torakochirurgia Polska\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.6000,\"publicationDate\":\"2023-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/99/46/KITP-20-51119.PMC10410641.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Kardiochirurgia I Torakochirurgia Polska\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5114/kitp.2023.129546\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kardiochirurgia I Torakochirurgia Polska","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/kitp.2023.129546","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

摘要

肺癌是全球癌症相关死亡的主要原因之一。上腔静脉综合征(SVCS)是一种罕见但可能危及生命的肺癌并发症,发生率约为5-10%。肺肿瘤浸润上腔细胞的手术治疗存在困难,但技术进步和创新的贡献是有希望的。与此同时,手术治疗患者生存率的改善也同样有希望。肺肿瘤引起的SVC侵犯的手术治疗结果因肿瘤的范围和患者的整体健康状况而异。然而,研究清楚地表明,手术治疗可以改善选定患者的生存和生活质量。文献回顾表明,对于侵犯上腔细胞的肺癌,手术入路是最不可或缺的治疗方法,有助于实现患者的长期生存。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Lung cancer invading the superior vena cava - surgical treatment. A short and up-to-date review.

Lung cancer is one of the leading causes of cancer-related deaths worldwide. Superior vena cava syndrome (SVCS) is a rare but potentially life-threatening complication of lung cancer, occurring in approximately 5-10% of cases. There are difficulties in the process of surgical treatment of SVC infiltrated by lung tumors but the contribution of technological evolution and innovation is promising. At the same time, the amelioration of survival rates of patients subjected to surgical treatment is equally promising. The reported outcomes of surgical treatment for SVC invasion due to lung tumors vary depending on the extent of the tumor and the patient's overall health status. However, studies clearly suggest that surgical treatment can improve survival and quality of life in selected patients. The literature review showed that the surgical approach to lung cancer invading the SVC constitutes the most indispensable treatment which helps to achieve the long-term survival of patients.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.90
自引率
14.30%
发文量
44
审稿时长
6-12 weeks
期刊介绍: Polish Journal of Thoracic and Cardiovascular Surgery is a quarterly aimed at cardiologists, cardiosurgeons and thoracic surgeons. Includes the original works (experimental, research and development), illustrative and casuistical works about cardiology and cardiosurgery.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信